Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.3.B
Wang H et al. (2021)
|
Xla Wt + wnt3a + chd1 + animal cap explant
NF15 (RT-PCR)
|
|
|
|
Fig.1.C
Wang H et al. (2021)
|
Xtr Wt + fermt2 CRISPR
NF15 (in situ hybridization)
|
|
|
|
Fig. 2.F,G
Wang H et al. (2021)
|
Xtr.fermt2tm-/- Huzha
NF15 (RT-PCR)
|
|
|
|
Fig. 4 G, Sup. Fig. 2 C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 5 A
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 6 A col 4
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 6 A col 2
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 + six1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 6 A col 3
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 + six1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 G P
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 L P
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF13-18 (in situ hybridization)
|
|
|